Vistide

This page contains recent news articles, when available, and an overview of Vistide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Vistide
(when available)

Pharmacology and use:
Cidofovir is a new anti-viral drug. It is classified as a nucleotide analogue and is active against herpes cytomegalovirus (CMV) retinitis infection. Most adults are infected with CMV. Cidofovir suppresses cytomegalovirus (CMV) replication by selective inhibition of viral DNA synthesis. Biochemical data support selective inhibition of CMV DNA polymerase by cidofovir diphosphate, the active intracellular metabolite of cidofovir. Cidofovir diphosphate inhibits herpesvirus polymerases at concentrations that are 8- to 600-fold lower than those needed to inhibit human cellular DNA polymerase alpha, beta, and gamma(1,2,3). Incorporation of cidofovir into the growing viral DNA chain results in reductions in the rate of viral DNA synthesis. For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS)

Mechanism Of Action:
Cidofovir acts through the selective inhibition of viral DNA polymerase.

News Articles on Cidofovir

Asia Times Online :: Asian News, Business and Economy.  -  Nov 4, 2005
The package also included injection with a drug named Vistide, ... Vistide was also a product of Gilead Sciences, and Rumsfeld was the person who signed off ... Asia Times Online

Rummy's bird flu bonanza  -  Nov 6, 2005
The package also included injection with a drug named Vistide, ... Vistide was also a product of Gilead Sciences, and Rumsfeld was the person who signed off ... mathaba.net

Gilead Sciences at Bear Stearns 19th Annual Healthcare Conference - …  -  Sep 12, 2006
And then, we have Tamiflu, Macugen and Vistide. ... And Vistide is a small contributor to the bottom line, but meets a severe unmet medical need. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Gilead Sciences at Goldman Sachs Health Care Conference - Final.  -  Jun 15, 2005
And then finally Vistide and Macugen. Vistide is a small contributor from the P&L perspective. It's an important unmet medical need, and then finally, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

ÄŒeský vÄ›dec dostane miliony na výzkum  -  Jul 13, 2006
Díky nÄ›mu a jeho týmu pomáhají nemocným preparáty Viread a Vistide, které zpomalují působení viru HIV. Lék Hepsera doktoÅ™i pÅ™edepisují k léÄ?bÄ› chronické ... AktuálnÄ›.cz

Gilead expands to new markets: BAY AREA MAKER OF HIV DRUGS …  -  Jun 15, 2007
That year, the FDA approved its drug Vistide, developed for cytomegalovirus retinitis, a condition related to the herpes virus, which can cause eye damage. ... Free with registration - San Jose Mercury News - AccessMyLibrary.com

Vymyslel lék na AIDS. Dostane za to Nobelovu cenu?  -  Oct 5, 2008
Vistide, jehož úÄ?innou látku profesor Holý objevil, si zase dokáže poradit s ... Vistide - 1996 Je antivirus, který úÄ?innÄ› působí například na pásové opary, ... Blesk.cz

|EL COMERCIO DE LA GRIPE AVIAR |  -  Apr 5, 2006
Que el Vistide fuera también un producto de los laboratorios Gilead Sciences Inc, creador del Tamiflu, es otra coincidencia. Así que siga usted de cerca ... mediosindependientes.org

æµ?感讓美防長拉æ°?å?£è¢‹é¼“起布什政府å†?é™·ä¿¡ä»»å?±æ©Ÿ- 亞洲時報  -  Nov 8, 2005
...此外,還�求注射一種�Vistide的藥物,以抑制天花疫苗的副作用。 Vistide�樣也是 �里德科學公�的產�,為�隊注射該藥物的命令就是拉姆斯�爾德簽署的。 ... 亞洲時報在線

Gilead products.  -  Jun 15, 2007
Vistide: For cytomegalovirus retinitis, a condition related to the herpes virus, which can cause eye damage. Approved for US sales in ... Free with registration - San Jose Mercury News - AccessMyLibrary.com

Gilead Sciences  -  Feb 28, 2005
Tamiflu, for the prevention and treatment of influenza; Vistide, for the treatment of cytomegalovirus retinitis in patients with AIDS; and DaunoXome, ... BusinessWeek

Investor Alert for Gilead Sciences Inc.  -  Jun 6, 2007
Other products on the market including AmBisome, used to treat systemic fungal infections, such as those that accompany AIDS; Vistide, to treat AIDS-related ... Free with registration - M2 Presswire - AccessMyLibrary.com

Antonín Holý: one of the country's most renowned scientists - Radio …  -  Aug 10, 2008
...transcriptase inhibitor – an unsuccessful HIV treatment now used to fight Hepatitis B or Vistide to treat retinal complications in AIDS patients. ... radio.cz

Healthcare sector to fight ATB over-consumption  -  Dec 20, 2008
His numerous discoveries include antivirotics used for the treatment of herpetic eruptions (Duvira, 1980, or Vistide, 1996), AIDS/HIV (Viread, ... European Hospital

Chimerix Raises $23.1 Million to Advance Antiviral Drug Pipeline  -  Feb 23, 2007
Chimerix has successfully applied ProLipTag technology to create CMX001, an antiviral compound developed from Gilead's marketed drug Vistide(TM). ... Genetic Engineering News - Genetic Engineering News (press release)

Gilead Sciences at Pacific Growth Equities 2006 Life Sciences Growth ...  -  Jun 13, 2006
The one we are most excited about today is or single tablet regimen which is our product Truvada co-formulated with [Vistide]. We hope to launch this very ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Gilead Sciences at Cowen & Co. 26th Annual Health Care …  -  Mar 6, 2006
Hepsera is for the treatment of Hepatitis B. Hepsera, Viread and [Vistide peridaunial] are nucleotide analogues. So 3 of our products are nucleotides. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Czech scientists claim US drugmaker shelving powerful new drug  -  Mar 7, 2007
The Czech scientific team has already invented a substance against the same types of viruses that Gilead markets as Vistide, a likely cause for the ... Monsters and Critics.com

Gilead Sciences at SG Cowen & Co. 25th Annual Health Care …  -  Mar 15, 2005
Vistide is a product that we don't talk about much. It will only be mentioned briefly here. It's an important unmet medical need. It works on CMV retinitis, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Article: Tenofovir beats adefovir at Hep B viral suppression.(Digestiv...  -  Mar 15, 2008
18, 1995--Gilead Sciences, Inc. (Nasdaq: GILD) announced ... progression of 120 days in the VISTIDE treated patients (5 mg/kg) versus 22 days in initially ... Pay-Per-View - Family Practice News - HighBeam Research

Options for treating ganciclovir-resistant CMV discussed at IDSA …  -  Oct 16, 2006
The current options are the intravenous drugs ganciclovir (Cymevene), foscarnet (Foscavir) and cidofovir (Vistide), and the oral valganciclovir (Valcyte.). ... Aidsmap

How to take Tenofovir from Consumer Reports Health.  -  Jan 6, 2007
Be sure to mention any of the following: antiviral medications such as acyclovir (Zovirax), cidofovir (Vistide), ganciclovir (Cytovene, Vitasert), ... consumerreports.org

Merger and Acquisition Scenario  -  Jan 26, 2008
Emtriva, Hepsera (adefovir dipivoxil), AmBisome (amphotericin B liposome for injection), Vistide (cidofovir injection) and Flolan (epoprostenol sodium). ... $250.00 - Revere Reports - Revere

Netherlands Corporate News - Gilead Sciences en IOCB zetten …  -  Jul 13, 2006
Rega Institute, were developed by Gilead, resulting in Vistide(R) (cidofovir injection) for the treatment of CMV retinitis in AIDS patients, ... Netherlands Corporate News - Netherlands Corporate News (persbericht)

Gilead Sciences at Sanford C. Bernstein & Co. Strategic Decisions...  -  Jun 1, 2005
Vistide is a small drug that we launched in 1996 for the treatment of CMV retinitis in AIDS patients. And Macugen is a recently launched the drug that we ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Gilead Sciences at Goldman Sachs 28th Annual Global Healthcare …  -  Jun 13, 2007
We've used both organic growth, so discovery of compounds such as Viread, Hepsera, Vistide, Tamiflu, as a way to further our pipeline, along with strategic ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Merger and Acquisition Scenario  -  Jan 26, 2008
Emtriva, Hepsera (adefovir dipivoxil), AmBisome (amphotericin B liposome for injection), Vistide (cidofovir injection) and Flolan (epoprostenol sodium). ... $250.00 - Revere Reports - Revere

Survival in patients with PML longer with protease inhibitor and...  -  Mar 27, 2006
...(PML) survive longer if they are treated with antiretroviral therapy including a protease inhibitor as well as the anti-viral drug cidofovir (Vistide). ... Aidsmap

Antivirals cope with influenza, cytomegalovirus and varicella-zoster...  -  May 1, 2005
1421d followed by 90-120 mg/kg IV once/d Cidofovir - Vistide 5 mg/kg IV once/wk x 2 then 5 mg/kg IV q2wks Fomivirsen - Vitravene 330 mcg intravitreally ... Free with registration - Managed Healthcare Executive - AccessMyLibrary.com

A Czech scientist and his team will receive millions of USD.  -  Jul 10, 2006
Besides, Mr. A. Holy developed the substance cidofovir, which is known s the medicine Vistide. He also participated in the development of the medicine ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com

Merger and Acquisition Scenario  -  Jun 16, 2007
Emtriva, Hepsera (adefovir dipivoxil), AmBisome (amphotericin B liposome for injection), Vistide (cidofovir injection) and Flolan (epoprostenol sodium). ... $250.00 - Revere Reports - Revere

Gilead Sciences at NewsMakers in the Biotech Industry - Final.  -  Sep 7, 2006
Macugen and Vistide are small contributors. This is our product pipeline. And again, you can see that there's quite a bit going on. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Ã?ndice de lecciones  -  Mar 1, 2008
Es importante ser cuidadoso al usar Viread en combinación con Vistide (cidofovir), Cytovene (ganciclovir), y Valcyte (valganciclovir), tres tratamientos ... AIDSmeds.com HIV/AIDS Treatment News

Article: HEALTH MATTERS: Drug allowed me to hope for the future.(News...  -  Sep 22, 2005
Under a treatment IND recently authorized by FDA, doctors may use the investigational drug intravenous Vistide (cidofovir) to treat HIV-infected patients ... Pay-Per-View - Birmingham Post - HighBeam Research

Merger and Acquisition Scenario  -  Apr 7, 2007
Emtriva, Hepsera (adefovir dipivoxil), AmBisome (amphotericin B liposome for injection), Vistide (cidofovir injection) and Flolan (epoprostenol sodium). ... $250.00 - Revere Reports - Revere

Should anal Pap smears be introduced for people with HIV?  -  Jun 26, 2006
At present, possible options include surgical removal, treatment with imiquimod (Aldara), fluorouracil (Efadix), cidofovir (Vistide) or interferon, ... Aidsmap

BE République Tchèque 7 >> 22/12/2008  -  Dec 22, 2008
Cette dernière fabrique et commercialise Viread ainsi que Vistide, autre molécule traitant le sida et ses symptômes, conçue également par le chimiste ... bulletins-electroniques.com

FDA approves generic version of Videx EC delayed release capsules.( …  -  Apr 1, 2005
Zovirax (acyclovir) or its generic version acyclovir, Valtrex (valacyclovir), Cytovene (ganciclovir), Valcyte (valgancyclovir), and Vistide (cidofovir . ... Pay-Per-View - HIV Treatment: ALERTS! - HighBeam Research

Press Release: Current Research on Gilead Sciences Inc. - M2 Presswire...  -  Feb 1, 2007
Other products on the market including AmBisome, used to treat systemic fungal infections, such as those that accompany AIDS; Vistide, to treat AIDS-related ... Pay-Per-View - M2 Presswire - HighBeam Research

Ð?кадемиÑ? наук: Следует изменить подход Ð?обелевÑ?кого комитета  -  Oct 1, 2008
Это вÑ?е на фоне уÑ?пешного иÑ?пользованиÑ? препаратов Vistide, более деÑ?Ñ?ти лет иÑ?пользуемого длÑ? лечениÑ? глазной инфекции, поражающей людей Ñ? оÑ?лабленной под ... radio.cz

Yellow-white retinal lesion in a 48-year-old woman.(Photo Quiz)  -  Aug 15, 2007
Intravenous ganciclovir (Cytovene), foscarnet (Foscavir), or cidofovir (Vistide) is used in the induction phase. (3) Oral formulations of ganciclovir and ... $4.95 - American Family Physician - ECNext

Imiquimod may clear superficial infantile hemangiomas.(Skin Disorders)...  -  Mar 15, 2005
Dr. Patricia M. Witman advised at a dermatology meeting sponsored by the Mayo Foundation. Cidofovir (Vistide) is already marketed by ... Pay-Per-View - Family Practice News - HighBeam Research

NejvÄ›tší ÄŒeskou hlavou je letos profesor Antonín Holý  -  Nov 19, 2008
Lék Hespera z roku 2002 zase působí proti viru žloutenky typu B. Už od roku 1996 se na základě preparátů profesora Antonína Holého vyrábí také lék Vistide, ... radio.cz

Vaccines; Researchers' data from the United States and Netherlands …  -  Oct 25, 2006
..."Here we compare the effectiveness of postexposure smallpox vaccination and antiviral treatment with either cidofovir (also called HPMPC or Vistide) or with ... Pay-Per-View - Immunotherapy Weekly - Factiva, from Dow Jones

Merger and Acquisition Scenario  -  Jan 27, 2007
...of fungal infection, and Vistide (cidofovir injection) for the treatment of cytomegalovirus infection. In August 2006, Gilead acquired Corus Pharma. ... $250.00 - Revere Reports - Revere

5-FU cream well tolerated for superficial basal cell carcinoma.(Skin ...  -  May 1, 2005
Dr. Patricia M. Witman advised at a dermatology meeting sponsored by the Mayo Foundation. Cidofovir (Vistide) is already marketed by ... Pay-Per-View - Family Practice News - HighBeam Research

ПрофеÑ?Ñ?ор Ð?нтонин Холы помогает людÑ?м жить  -  Apr 5, 2008
Ð’ 1996 году поÑ?вилÑ?Ñ? препарат Vistide, который иÑ?пользуетÑ?Ñ? длÑ? лечениÑ? глазной инфекции, поражающей людей Ñ? оÑ?лабленной под влиÑ?нием ВИЧ имунной Ñ?иÑ?темой. ... radio.cz

Merger and Acquisition Scenario  -  May 19, 2007
Emtriva, Hepsera (adefovir dipivoxil), AmBisome (amphotericin B liposome for injection), Vistide (cidofovir injection) and Flolan (epoprostenol sodium). ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 19, 2006
B liposome for injection) for the treatment of fungal infection, and Vistide (cidofovir injection) for the treatment of cytomegalovirus (CMV) infection. ... $250.00 - Revere Reports - Revere

Le litige concernant la nouvelle Bibliothèque nationale toujours sans...  -  Feb 28, 2008
...du médicament contre l'hépatite B, Hepsera, et de deux antiviraux Viread et Vistide contre le sida qui sont commercialisés sur 52% du marché mondial. ... radio.cz

Merger and Acquisition Scenario  -  Nov 25, 2006
...of fungal infection, and Vistide (cidofovir injection) for the treatment of cytomegalovirus infection. In August 2006, Gilead acquired Corus Pharma. ... $250.00 - Revere Reports - Revere

Press Release: Current Research on Gilead Sciences Inc. - M2 Presswire...  -  Jun 25, 2007
Other products on the market including AmBisome, used to treat systemic fungal infections, such as those that accompany AIDS; Vistide, to treat AIDS-related ... Pay-Per-View - M2 Presswire - HighBeam Research

Leucoencefalopatía multifocal progresiva (LMP)  -  Sep 20, 2005
...clínicos incluyen: cystosine arabinoside (Cytosar-U, DepoCyt), topotecan (Hycamtin), cidofovir (Vistide), y dosis endovenosas altas de AZT (Retrovir). ... AIDSmeds.com HIV/AIDS Treatment News

Erasmus University, Netherlands; Medical findings reported by Erasmus...  -  Nov 14, 2006
..."Here we compare the effectiveness of postexposure smallpox vaccination and antiviral treatment with either cidofovir (also called HPMPC or Vistide) or with ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Press Release: Investor Alert for Gilead Sciences Inc. - M2 Presswire...  -  Jun 6, 2007
Other products on the market including AmBisome, used to treat systemic fungal infections, such as those that accompany AIDS; Vistide, to treat AIDS-related ... Pay-Per-View - M2 Presswire - HighBeam Research

Gilead to donate $1.1M a year to Czech IOCB.  -  Jul 24, 2006
Several of the resulting compounds were commercialized by the California-headquartered firm, including: Vistide (cidofovir injection), for the treatment of ... $9.94 - Pharma Marketletter - Alacra Store

Merger and Acquisition Scenario  -  Dec 16, 2006
...of fungal infection, and Vistide (cidofovir injection) for the treatment of cytomegalovirus infection. In August 2006, Gilead acquired Corus Pharma. ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  May 13, 2006
B liposome for injection) for the treatment of fungal infection, and Vistide (cidofovir injection) for the treatment of cytomegalovirus (CMV) infection. ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 2, 2006
B liposome for injection) for the treatment of fungal infection, and Vistide (cidofovir injection) for the treatment of cytomegalovirus (CMV) infection. ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Dec 16, 2006
...of fungal infection, and Vistide (cidofovir injection) for the treatment of cytomegalovirus infection. In August 2006, Gilead acquired Corus Pharma. ... $250.00 - Revere Reports - Revere

Press Release: Chimerix Raises $23.1 Million to Advance Antiviral...  -  Feb 23, 2007
Chimerix has successfully applied ProLipTag technology to create CMX001, an antiviral compound developed from Gilead's marketed drug Vistide(TM). ... Pay-Per-View - PR Newswire - HighBeam Research

Merger and Acquisition Scenario  -  Aug 19, 2006
B liposome for injection) for the treatment of fungal infection, and Vistide (cidofovir injection) for the treatment of cytomegalovirus (CMV) infection. ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Apr 15, 2006
B liposome for injection) for the treatment of fungal infection, and Vistide (cidofovir injection) for the treatment of cytomegalovirus (CMV) infection. ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Nov 4, 2006
B liposome for injection) for the treatment of fungal infection, and Vistide (cidofovir injection) for the treatment of cytomegalovirus (CMV) infection. ... $250.00 - Revere Reports - Revere

Smallpox Vaccine; Monkeypox virus infection is more effectively...  -  Mar 28, 2006
..."Here we compare the effectiveness of postexposure smallpox vaccination and antiviral treatment with either cidofovir (also called HPMPC or Vistide) or with ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Merger and Acquisition Scenario  -  Mar 11, 2006
B liposome for injection) for the treatment of fungal infection, and Vistide (cidofovir injection) for the treatment of cytomegalovirus (CMV) infection. ... $250.00 - Revere Reports - Revere

Gilead Sciences sagenhafte Gewinnchance  -  Sep 28, 2007
Der Durchbruch sei 1996 gelungen, als mit Vistide das erste eigene Präparat für AIDS-Patienten auf den Markt gebracht worden sei. ... Euro am Sonntag

El negocio del crimen  -  Mar 26, 2006
...los soldados estadounidenses fueron tratados de los efectos secundarios de la vacuna contra la viruela con un fármaco llamado Vistide, que el gobierno ... rebelion.org

Leucoencefalopatía multifocal progresiva (LMP)  -  Jul 6, 2006
DepoCyt®), topotecan (Hycamtin®), cidofovir (Vistide)®, y dosis endovenosas altas de AZT (Retrovir®). Algunos demostraron ser muy tóxicos para su uso, ... AIDSmeds.com HIV/AIDS Treatment News

John Libbey Eurotext : Éditions médicales et scientifiques France :...  -  Dec 5, 2006
Il repose sur l'interféron α humain recombinant, Introna ® [1] ou le cidofovir, Vistide ® [1, 4]. L'utilisation du cidofovir a été proposée par voie IV ou ... john-libbey-eurotext.fr

ЧешÑ?кие ученые получили грант на открытие иÑ?Ñ?ледовательÑ?ког?  -  Jul 14, 2006
американÑ?каÑ? фирма иÑ?пользовала длÑ? Ñ?озданиÑ? неÑ?кольких лекарÑ?твенных препаратов длÑ? борьбы Ñ?о СПИДом, таких, например, как Viread, Truvada, Vistide. ... radio.cz

Brand Names/Synonyms:
Vistide is also known by the following brand names and/or synonymsCDV; Cidofovir; Cidofovir Anhydrous; GS 0504; GS504; HPMPC; HSDB 7115; Vistide

Drug Category:
Vistide is categorized under the following by the FDA: Anti-HIV Agents; Radiation-Sensitizing Agents; Antivirals; Antineoplastic Agents; ATC:J05AB12

Dosage Forms:
parenteral

Absorption:
100%

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
[1-[(4-amino-2-oxo-1H-pyrimidin-1-yl)methyl]-2-hydroxy-ethoxy]methylphosphonicacid





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy